Promotion of rational medication use in elderly patients with Parkinson's disease through drug use risk management
10.3760/cma.j.issn.0254-9026.2024.11.021
- VernacularTitle:老年帕金森病患者临床用药的风险管理
- Author:
Xuelin SUN
1
;
Dongfang QIAN
;
Wenjing ZHAO
;
Xi WANG
;
Yatong ZHANG
;
Xin HU
Author Information
1. 北京医院药学部 国家老年医学研究中心 中国医学科学院老年医学研究院，北京 100730
- Keywords:
Parkinson disease;
Rational use of drug;
Risk management of drug use
- From:
Chinese Journal of Geriatrics
2024;43(11):1496-1501
- CountryChina
- Language:Chinese
-
Abstract:
Parkinson's disease(PD)is a prevalent condition among the elderly, with its incidence increasing with age and significantly affecting the quality of life in this demographic.Given the unique characteristics of older adults, such as comorbidities, polypharmacy, and reduced sensitivity to treatment regimens, it is essential to not only focus on the efficacy of medications used in PD treatment but also to carefully evaluate the associated drug risks.This article examines a drug risk management approach for treating elderly patients with PD, emphasizing the importance of gathering comprehensive drug information, identifying potential risks associated with drug selection, procurement, storage, prescription, and dispensing, and addressing specific considerations pertinent to the elderly population.Furthermore, the article proposes management strategies aimed at standardizing risk management in the treatment of elderly patients with PD, enhancing clinical pharmacy services in this area, and promoting rational drug use among this vulnerable group.
